Sex-Based Disparities in the Transition to Dolutegravir-Based Antiretroviral Therapy in West African HIV Cohorts.

Autor:	Tiendrebeogo, Thierry, Malateste, Karen, Poda, Armel, Minga, Albert, Messou, Eugene, Chenal, Henri, Ezechi, Oliver, Ekouevi, Didier K, Ofotokun, Igho, Jaquet, Antoine, Collaboration, IeDEA West Africa
Předmět:	ANTIRETROVIRAL agents HIV DOLUTEGRAVIR PROTEASE inhibitors
Zdroj:	Open Forum Infectious Diseases; May2024, Vol. 11 Issue 5, p1-5, 5p
Abstrakt:	Transition to dolutegravir among 21 167 individuals experienced in antiretroviral therapy in West Africa showed heterogeneous timelines and patterns. Initially reported sex disparities tended to catch up over time with persisting disparities, according to contributing HIV clinics. Key factors facilitating dolutegravir switch were male sex, age <50 years, viral suppression, and regimens not based on protease inhibitors. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.